{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T11:46:01Z","timestamp":1782474361212,"version":"3.54.5"},"reference-count":72,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,4,13]],"date-time":"2013-04-13T00:00:00Z","timestamp":1365811200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[2013,9]]},"DOI":"10.1007\/s00213-013-3091-z","type":"journal-article","created":{"date-parts":[[2013,4,12]],"date-time":"2013-04-12T03:02:23Z","timestamp":1365735743000},"page":"95-103","source":"Crossref","is-referenced-by-count":20,"title":["Effects of amisulpride on human resting cerebral perfusion"],"prefix":"10.1007","volume":"229","author":[{"given":"Roberto","family":"Viviani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heiko","family":"Graf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maike","family":"Wiegers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Birgit","family":"Abler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,4,13]]},"reference":[{"key":"3091_CR1","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s00213-009-1521-8","volume":"205","author":"AI Abbas","year":"2009","unstructured":"Abbas AI, Hedlund PB, Huang XP, Tran TB, Meltzer HY, Roth BL (2009) Amisulpride is a potent 5-HT7 antagonist: Relevance for antidepressant actions in vivo. Psychopharmacol (Berl) 205:119\u2013128","journal-title":"Psychopharmacol (Berl)"},{"key":"3091_CR2","doi-asserted-by":"crossref","first-page":"e54447","DOI":"10.1371\/journal.pone.0054447","volume":"8","author":"B Abler","year":"2013","unstructured":"Abler B, Kumpfm\u00fcller D, Gr\u00f6n G, Walter M, Stingl J, Seeringer A (2013) Neural correlates of erotic stimulation under different levels of female sexual hormones. PLoS One 8:e54447","journal-title":"PLoS One"},{"key":"3091_CR3","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1096\/fj.06-6509com","volume":"21","author":"C Andriamampandry","year":"2007","unstructured":"Andriamampandry C, Taleb O, Kemmel V, Humbert JP, Aunis D, Maitre M (2007) Cloning and functional characterization of a gamma-hydroxybutyrate receptor identified in the human brain. FASEB J 21:885\u2013895","journal-title":"FASEB J"},{"key":"3091_CR4","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1176\/ajp.151.5.681","volume":"151","author":"EJ Bartlett","year":"1994","unstructured":"Bartlett EJ, Brodie JD, Simkowitz P, Dewey SL, Rusinek H, Wolf AP, Fowler JS, Volkow ND, Smith G, Wolkin A, Cancro R (1994) Effects of haloperidol challenge on regional cerebral glucose utilization in normal human subjects. Am J Psychiatry 151:681\u2013686","journal-title":"Am J Psychiatry"},{"key":"3091_CR5","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1177\/0269881111421975","volume":"26","author":"OG Bosch","year":"2012","unstructured":"Bosch OG, Quednov BB, Seifritz E, Wetter TC (2012) Reconsidering GHB: Orphan drug or new model antidepressant? J Psychopharm 26:618\u2013628","journal-title":"J Psychopharm"},{"key":"3091_CR6","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1176\/appi.ajp.160.8.1413","volume":"160","author":"RA Bressan","year":"2003","unstructured":"Bressan RA, Erlandsson K, Jones HM, Mulligan R, Flanagan RJ, Ell PJ, Pilowsky LS (2003) Is regionally selective D2\/D3 dopamine occupancy sufficient for atypical antipsychotic effect? An in vivo quantitative [123I]Epidepride SPET study of amisulpride-treated patients. Am J Psychiatry 160:1413\u20131420","journal-title":"Am J Psychiatry"},{"key":"3091_CR7","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1002\/mrm.21779","volume":"61","author":"A Bruns","year":"2009","unstructured":"Bruns A, K\u00fcnnecke B, Risterucci C, Moreau JL, von Kienlin M (2009) Validation of cerebral blood perfusion imaging as a modality for quantitative pharmacological MRI in rats. Magn Reson Med 61:1451\u20131458","journal-title":"Magn Reson Med"},{"key":"3091_CR8","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.pharmthera.2008.10.003","volume":"121","author":"LP Carter","year":"2009","unstructured":"Carter LP, Koek W, France CP (2009) Behavioural analyses of GHB: Receptor mechanisms. Pharmacol Ther 121:100\u2013114","journal-title":"Pharmacol Ther"},{"key":"3091_CR9","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/clpt.2010.296","volume":"89","author":"Y Chen","year":"2011","unstructured":"Chen Y, Wan HI, O\u2019Reardon JP, Wang DJJ, Wang Z, Korczykowski M, Detre JA (2011) Quantification of cerebral blood flow as biomarker of drug effect: Arterial spin labeling phMRI after a single dose of oral citalopram. Clin Pharmacol Ther 89:251\u2013258","journal-title":"Clin Pharmacol Ther"},{"key":"3091_CR10","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.coph.2005.10.001","volume":"6","author":"V Crunelli","year":"2006","unstructured":"Crunelli V, Emri Z, Leresche N (2006) Unravelling the brain targets of \u03b3-hydroxybutyric acid. Curr Opin Pharmacol 6:44\u201352","journal-title":"Curr Opin Pharmacol"},{"key":"3091_CR11","first-page":"454","volume":"3","author":"JA Detre","year":"1992","unstructured":"Detre JA, Leigh JS, Williams DS, Koretsky AP (1992) Perfusion imaging. Magn Reson Med 3:454\u2013462","journal-title":"Magn Reson Med"},{"key":"3091_CR12","first-page":"535","volume":"42","author":"MD Devous","year":"2001","unstructured":"Devous MD, Trivedi MH, Rush AJ (2001) Regional cerebral blood flow response to oral amphetamine challenge in healthy volunteers. J Nucl Med 42:535\u2013542","journal-title":"J Nucl Med"},{"key":"3091_CR13","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1001\/archpsyc.64.3.327","volume":"64","author":"BW Dunlop","year":"2007","unstructured":"Dunlop BW, Nemeroff CB (2007) The role of dopamine in the pathophysiology of depression. Arch Gen Psychiatry 64:327\u2013337","journal-title":"Arch Gen Psychiatry"},{"key":"3091_CR14","doi-asserted-by":"crossref","unstructured":"Farde L, Nordstr\u00f6m AL, Wiesel FA, Pauli S, Halldin C, Sedvall G (1992) Positron emission tomographic analysis of central D1 and D2 dopamine receptor occupancy in patients treated with classical neuroleptics and clozapine. Relation to extrapyramidal side effects. Arch Gen Psychiatry 49:538\u2013544","DOI":"10.1001\/archpsyc.1992.01820070032005"},{"key":"3091_CR15","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1111\/j.1476-5381.2010.01161.x","volume":"163","author":"MA Fern\u00e1ndez-Seara","year":"2011","unstructured":"Fern\u00e1ndez-Seara MA, Azn\u00e1rez-Sanado M, Mengual E, Irigoyen J, Heukamp F, Pastor MA (2011) Effects on resting state cerebral blood flow and functional connectivity induced by metoclopramide: A perfusion MRI study in healthy volunteers. Br J Pharmacol 163:1639\u20131652","journal-title":"Br J Pharmacol"},{"key":"3091_CR16","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1002\/jmri.10416","volume":"18","author":"TF Floyd","year":"2003","unstructured":"Floyd TF, Ratcliffe SJ, Wang J, Resch B, Detre JA (2003) Precision of the CASL-perfusion MRI technique for the measurement of cerebral blood flow in whole brain and vascular territories. J Magn Reson Imaging 18:649\u2013655","journal-title":"J Magn Reson Imaging"},{"issue":"suppl 2","key":"3091_CR17","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1097\/00004850-199705002-00004","volume":"12","author":"HL Freeman","year":"1997","unstructured":"Freeman HL (1997) Amisulpride compared with standard neuroleptics in acute exacerbations of schizophrenia: Three efficacy studies. Int Clin Psychopharmacol 12(suppl 2):S11\u2013S17","journal-title":"Int Clin Psychopharmacol"},{"key":"3091_CR18","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s00406-003-0401-1","volume":"253","author":"AS Gonul","year":"2003","unstructured":"Gonul AS, Kula M, Sofuoglu S, Tutus A, Esel E (2003) Tc-99 HMPAO SPECT study of regional cerebral blood flow in olanzapine-treated schizophrenic patients. Eur Arch Psychiatry Clin Neurosci 253:29\u201333","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"3091_CR19","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1002\/hbm.21436","volume":"34","author":"R Handley","year":"2013","unstructured":"Handley R, Zelaya FO, Reinders AATS, Reis Marques T, Mehta MA, O\u2019Gorman R, Alsop DC, Taylor H, Johnston A, Williams S, McGuire P, Pariante CM, Kapur S, Dazzan P (2013) Acute effects of single-dose aripiprazole and haloperidol on resting cerebral blood flow (rCBF) in the human brain. Hum Br Mapping 34:272\u2013282","journal-title":"Hum Br Mapping"},{"key":"3091_CR20","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/0006-8993(92)90498-X","volume":"572","author":"V Hechler","year":"1992","unstructured":"Hechler V, Gobaille S, Maitre M (1992) Selective distribution pattern of \u03b3-hydroxybutyrate receptors in the rat forebrain and midbrain as revealed by quantitative autoradiography. Brain Res 572:345\u2013348","journal-title":"Brain Res"},{"key":"3091_CR21","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1016\/S0022-3565(25)10159-6","volume":"264","author":"V Hechler","year":"1993","unstructured":"Hechler V, Peter P, Goabille S, Bourgouignon JJ, Schmitt M, Ehrhardt JD, Mak J, Maittre M (1993) \u03b3-hydroxybutyrate ligands possess antidopaminergic and neuroleptic-like activities. J Pharmacol Exp Ther 264:1406\u20131414","journal-title":"J Pharmacol Exp Ther"},{"key":"3091_CR22","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s00213-009-1626-0","volume":"206","author":"PB Hedlund","year":"2009","unstructured":"Hedlund PB (2009) The 5-HT7 receptor and disorders of the nervous system: An overview. Psychopharmacol (Berl) 206:345\u2013354","journal-title":"Psychopharmacol (Berl)"},{"key":"3091_CR23","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1176\/ajp.153.1.41","volume":"153","author":"HH Holcomb","year":"1996","unstructured":"Holcomb HH, Cascella NG, Thaker GK, Medoff DR, Dannals RF, Tamminga CA (1996) Functional sites of neuroleptic drug action in the human brain: PET\/FDG studies with and without haloperidol. Am J Psychiatry 153:41\u201349","journal-title":"Am J Psychiatry"},{"key":"3091_CR24","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1097\/00004647-199601000-00002","volume":"16","author":"AP Holmes","year":"1996","unstructured":"Holmes AP, Blair RC, Watson JDG, Ford I (1996) Nonparametric analysis of statistic images from functional mapping experiments. J Cereb Blood Flow Metab 16:7\u201322","journal-title":"J Cereb Blood Flow Metab"},{"key":"3091_CR25","doi-asserted-by":"crossref","unstructured":"Jenkins BG (2012) Pharmacologic magnetic resonance imaging (phMRI): Imaging drug action in the brain. NeuroImage 62:1072\u20131085","DOI":"10.1016\/j.neuroimage.2012.03.075"},{"key":"3091_CR26","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1176\/appi.ajp.157.4.514","volume":"157","author":"S Kapur","year":"2000","unstructured":"Kapur S, Zipursky R, Jones C, Remington G, Houle S (2000) Relationship between dopamine D2 occupancy, clinical response, and side effects: A double-blind PET study of first-episode schizophrenia. Am J Psychiatry 157:514\u2013520","journal-title":"Am J Psychiatry"},{"key":"3091_CR27","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1176\/ajp.156.2.286","volume":"156","author":"S Kapur","year":"1999","unstructured":"Kapur S, Zipursky RB, Remington G (1999) Clinical and theoretical implications of 5-HT2 and D2 receptor occupancy of clozapine, risperidone, and olanzapine in schizophrenia. Am J Psychiatry 156:286\u2013293","journal-title":"Am J Psychiatry"},{"key":"3091_CR28","doi-asserted-by":"crossref","unstructured":"Kim E, Howes OD, Turkheimer FE, Kim BH, Jeong JM, Kim JW, Lee JS, Jang IJ, Shi SG, Kapur S, Kown JS (2012) The relationship between antipsychotic D2 occupancy and change in frontal metabolism and working memory. Psychopharmacol (Berl) doi: 10.1007\/s00213-012-2953-0 . (epub ahead of print)","DOI":"10.1007\/s00213-012-2953-0"},{"key":"3091_CR29","first-page":"1028","volume":"46","author":"C Foug\u00e8re la","year":"2005","unstructured":"la Foug\u00e8re C, Meisenzahl E, Schmitt G, Stauss J, Frodl T, Tatsch K, Hahn K, M\u00f6ller HJ, Dresel S (2005) D2 receptor occupancy during high- and low-dose therapy with the atypical antipsychotic amisulpride: A 123I-Iodobenzamide SPECT study. J Nucl Med 46:1028\u20131033","journal-title":"J Nucl Med"},{"key":"3091_CR30","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/S0006-3223(02)01602-5","volume":"53","author":"AC Lahti","year":"2003","unstructured":"Lahti AC, Holcomb HH, Weiler MA, Medoff DR, Tamminga CA (2003) Functional effects of antipsychotic drugs: Comparing clozapine with haloperidol. Biol Psychiatry 53:601\u2013608","journal-title":"Biol Psychiatry"},{"key":"3091_CR31","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.pscychresns.2005.02.006","volume":"139","author":"AC Lahti","year":"2005","unstructured":"Lahti AC, Weiler MA, Medoff DR, Tamminga CA, Holcomb HH (2005) Functional effects of single dose first- and second-generation antipsychotic administration in subjects with schizophrenia. Psych Res Neuroimaging 139:19\u201330","journal-title":"Psych Res Neuroimaging"},{"key":"3091_CR32","doi-asserted-by":"crossref","first-page":"5103","DOI":"10.1021\/jm070516u","volume":"50","author":"JHM Lange","year":"2007","unstructured":"Lange JHM, Reinders JH, Tolboom JTBM, Glennon JC, Coolen HKAC, Kruse CG (2007) Principal component analysis differentiates the receptor binding profiles of three antipsychotic drug candidates from current antipsychotic drugs. J Med Chem 50:5103\u20135108","journal-title":"J Med Chem"},{"key":"3091_CR33","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.pharmthera.2010.08.013","volume":"129","author":"M Lepoldo","year":"2011","unstructured":"Lepoldo M, Lacivita E, Berardi F, Perrone R, Hedlund PB (2011) Serotonin 5-HT7 receptor agents: Structure-activity relationships and potential therapeutic appications in central nervous system disorders. Pharmacol Ther 129:120\u2013148","journal-title":"Pharmacol Ther"},{"key":"3091_CR34","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/S0301-0082(96)00064-0","volume":"51","author":"M Maitre","year":"1997","unstructured":"Maitre M (1997) The \u03b3-hydroxybutyrate signalling system in brain: Organization and functional implications. Progr Neurobiol 51:337\u2013361","journal-title":"Progr Neurobiol"},{"key":"3091_CR35","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/0014-2999(94)90248-8","volume":"256","author":"M Maitre","year":"1994","unstructured":"Maitre M, Ratomponirina C, Gobaille S, Hod\u00e9 Y, Hechler V (1994) Displacement of [3H]\u03b3-hydroxybutyrate binding by benzamide neuroleptics and prochlorperazine but not by other antipsychotics. Eur J Pharmacol 256:211\u2013214","journal-title":"Eur J Pharmacol"},{"key":"3091_CR36","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1007\/BF02245616","volume":"124","author":"JL Martinot","year":"1996","unstructured":"Martinot JL, Paill\u00e8re-Martinot ML, Poirier MF, Dao-Castellana MH, Loc\u2019h C, Mazi\u00e8re B (1996) In vivo characteristics of dopamine D2 receptor occupancy by amisulpride in schizophrenia. Psychopharmacol (Berl) 124:154\u2013158","journal-title":"Psychopharmacol (Berl)"},{"key":"3091_CR37","doi-asserted-by":"crossref","first-page":"933","DOI":"10.2165\/00023210-200418130-00007","volume":"18","author":"K McKeage","year":"2004","unstructured":"McKeage K, Plosker GL (2004) Amisulpride: A review of its use in the management of schizophrenia. CNS Drugs 18:933\u2013956","journal-title":"CNS Drugs"},{"key":"3091_CR38","doi-asserted-by":"crossref","first-page":"106S","DOI":"10.1016\/S0893-133X(99)00046-9","volume":"21","author":"HY Meltzer","year":"1999","unstructured":"Meltzer HY (1999) The role of serotonin in antipsychotic drug action. Neuropsychopharmacology 21:106S\u2013115S","journal-title":"Neuropsychopharmacology"},{"key":"3091_CR39","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/S0022-3565(25)20710-8","volume":"251","author":"HY Meltzer","year":"1989","unstructured":"Meltzer HY, Matsubara S, Lee JC (1989) Classification of typical and atypical antipsychotic drugs on the basis of dopamine D-1, D-2 and serotonin2 Pki values. J Pharmacol Exp Ther 251:238\u2013246","journal-title":"J Pharmacol Exp Ther"},{"key":"3091_CR40","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/S0006-3223(00)01001-5","volume":"49","author":"DD Miller","year":"2001","unstructured":"Miller DD, Andreasen NC, O\u2019Leary DS, Watkins GL, Boles Ponto LL, Hichwa RD (2001) Comparison of the effects of risperidone and haloperidol on regional cerebral blood flow in schizophrenia. Biol Psychiatry 49:704\u2013715","journal-title":"Biol Psychiatry"},{"key":"3091_CR41","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/S0893-133X(97)00042-0","volume":"17","author":"DD Miller","year":"1997","unstructured":"Miller DD, Andreasen NC, O\u2019Leary DS, Rezai K, Watkins L, Boles Ponto LL, Hichwa RD (1997a) Effect of antipsychotics on regional cerebral blood flow measured with positron emission tomography. Neuropsychopharmacology 17:230\u2013240","journal-title":"Neuropsychopharmacology"},{"key":"3091_CR42","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/S0006-3223(96)00110-2","volume":"41","author":"DD Miller","year":"1997","unstructured":"Miller DD, Rezai K, Alliger R, Andreasen NC (1997b) The effect of antipsychotic medication on relative cerebral blood perfusion in schizophrenia: Assessment with Technetium-99\u00a0m Hexamethyl-Propyleneamine Oxime single photon emission computer tomography. Biol Psychiatry 41:550\u2013559","journal-title":"Biol Psychiatry"},{"key":"3091_CR43","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1038\/npp.2011.13","volume":"36","author":"O Mnie-Filali","year":"2011","unstructured":"Mnie-Filali O, Faure C, Lamb\u00e1s-Senas L, El Mansari M, Belblidia H, Gondard E, Et\u00e9vant A, Scarna H, Didier A, Berod A, Blier P, Haddjeri N (2011) Pharmacological blockade of 5-HT7 receptors as a putative fast acting antidepressant strategy. Neuropsychopharmacology 36:1275\u20131288","journal-title":"Neuropsychopharmacology"},{"key":"3091_CR44","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1097\/00004850-200201000-00002","volume":"17","author":"SA Montgomery","year":"2002","unstructured":"Montgomery SA (2002) Dopaminergic deficit and the role of amisulpride in the treatment of mood disorders. Int Clin Psychopharmacol 17:S9\u2013S15","journal-title":"Int Clin Psychopharmacol"},{"key":"3091_CR45","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.neuroimage.2012.11.035","volume":"68","author":"LE Nordin","year":"2013","unstructured":"Nordin LE, Li TQ, Brogren J, Johansson P, Sj\u00f6gren N, Hannesdottir K, Bj\u00f6rk C, Segerdahl M, Wang DJJ, Julin P (2013) Cortical responses to amphetamine exposure by pCASL MRI and pharmacokinetic\/pharmacodynamic dose modeling. NeuroImage 68:75\u201382","journal-title":"NeuroImage"},{"key":"3091_CR46","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/0006-3223(93)90288-O","volume":"33","author":"AL Nordstr\u00f6m","year":"1993","unstructured":"Nordstr\u00f6m AL, Farde L, Wiesel FA, Forslund K, Pauli S, Halldin C, Uppfeldt G (1993) Central D2-dopamine receptor occupancy in relation to antipsychotic drug effects: A double-blind PET sutdy of schizophrenic patients. Biol Psychiatry 33:227\u2013235","journal-title":"Biol Psychiatry"},{"key":"3091_CR47","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/0306-3623(82)90088-X","volume":"13","author":"SE O\u2019Connor","year":"1982","unstructured":"O\u2019Connor SE, Brown RA (1982) The pharmacology of sulpiride, a dopamine receptor antagonist. Gen Pharmacol 13:185\u2013193","journal-title":"Gen Pharmacol"},{"key":"3091_CR48","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0022-3565(24)36394-3","volume":"280","author":"GH Perrault","year":"1997","unstructured":"Perrault GH, Depoortere R, Morel E, Sanger DJ, Scatton B (1997) Psychopharmacological profile of amisulpride: An antipsychotic drug with presynaptic D2\/D3 dopamine receptor antagonist activity and limbic selectivity. J Pharmacol Exp Ther 280:73\u201382","journal-title":"J Pharmacol Exp Ther"},{"key":"3091_CR49","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1159\/000079104","volume":"50","author":"G Racagni","year":"2004","unstructured":"Racagni G, Canonico PL, Ravizza L, Pani L, Amore M (2004) Consensus on the use of substituted benzamides in psychiatric patients. Neuropsychobiology 50:134\u2013143","journal-title":"Neuropsychobiology"},{"key":"3091_CR50","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1113\/jphysiol.1993.sp019913","volume":"471","author":"SC Ramsay","year":"1993","unstructured":"Ramsay SC, Murphy K, Shea SA, Friston KJ, Lammertsma AA, Clark JC, Adams L, Guz A, Frackowiak RSJ (1993) Changes in global cerebral blood flow in humans: Effect on regional cerebral blood flow during a neural activation task. J Physiol (Lond) 471:521\u2013534","journal-title":"J Physiol (Lond)"},{"key":"3091_CR51","doi-asserted-by":"crossref","unstructured":"Rose SE, Chalk JB, Janke AL, Strudwick MW, Windus LC, Hannah DE, McGrath JJ, Pantelis C, Wood SJ, Mowry BJ (2006) Assessment of dynamic susceptibility contrast cerebral blood flow response to amphetamine challenge: A human pharmacological magnetic resonance imaging study at 1.5 and 4 T. Magn Reson Med 55:9\u201315","DOI":"10.1002\/mrm.20749"},{"key":"3091_CR52","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1016\/S0022-3565(25)38596-4","volume":"268","author":"BL Roth","year":"1994","unstructured":"Roth BL, Craigo SC, Choudhary MS, Uluer A, Monsma FJ, Shen Y, Meltzer HY, Sibley DR (1994) Binding of typical and atypical antipsychotic agents to 5-hydroxytryptamine-6 and 5-hydroxytryptamine-7 receptors. J Pharmacol Exp Ther 268:1403\u20131410","journal-title":"J Pharmacol Exp Ther"},{"key":"3091_CR53","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0022-3565(24)36395-5","volume":"280","author":"H Schoemaker","year":"1997","unstructured":"Schoemaker H, Claustre Y, Fage D, Rouquier L, Chrgui K, Curet O, Oblin A, Gonon F, Carter C, Benavides J, Scatton B (1997) Neurochemical characteristics of amisulpride, an atypical dopamine D2\/D3 receptor antagonist with both presynaptic and limbic selectivity. J Pharmacol Exp Ther 280:83\u201397","journal-title":"J Pharmacol Exp Ther"},{"key":"3091_CR54","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1038\/sj.npp.1300203","volume":"28","author":"DA Shapiro","year":"2003","unstructured":"Shapiro DA, Renock S, Arrington E, Chiodo LA, Liu LX, Sibley DR, Roth BL, Mailman R (2003) Aripiprazole, a novel atypical antipsychotic drug with a unique and robust pharmacology. Neuropsychopharmacology 28:1400\u20131411","journal-title":"Neuropsychopharmacology"},{"key":"3091_CR55","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/mrm.1910330210","volume":"33","author":"AC Silva","year":"1995","unstructured":"Silva AC, Zhang W, Williams DS, Koretsky AP (1995) Multi-slice MRI of rat brain perfusion during amphetamine stimulation using arterial spin labeling. Magn Reson Med 33:209\u2013214","journal-title":"Magn Reson Med"},{"key":"3091_CR56","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0165-0327(97)00139-0","volume":"48","author":"E Smeraldi","year":"1998","unstructured":"Smeraldi E (1998) Amisulpride versus fluoxetine in patients with dysthymia or major depression in partial remission: A double blind, comparative study. J Affect Dis 48:47\u201356","journal-title":"J Affect Dis"},{"key":"3091_CR57","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1111\/j.1600-0447.2009.01429.x","volume":"120","author":"A Sparshatt","year":"2009","unstructured":"Sparshatt A, Taylor D, Paterl MX, Kapur S (2009) Amisulpride - Dose, plasma concentration, occupancy and response: Implications for therapeutic drug monitoring. Acta Psychiatr Scand 120:416\u2013428","journal-title":"Acta Psychiatr Scand"},{"key":"3091_CR58","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1016\/j.pnpbp.2003.09.009","volume":"27","author":"TH Svensson","year":"2003","unstructured":"Svensson TH (2003) \u03b1-adrenoceptor modulation hypothesis of antipsychotic atypicality. Prog Neuropsychopharmacol Biol Psychiatry 27:1145\u20131158","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"3091_CR59","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1176\/ajp.155.4.505","volume":"155","author":"C Trichard","year":"1998","unstructured":"Trichard C, Paill\u00e8re-Martinot ML, Attar-Levy D, Recassens C, Monnet F, Martinot JL (1998) Binding of antipsychotic drugs to cortical 5-HT2A receptors: A PET study of chlorpromazine, clozapine, and amisulpride in schizophrenic patients. Am J Psychiatry 155:505\u2013508","journal-title":"Am J Psychiatry"},{"key":"3091_CR60","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1017\/S1461145704004353","volume":"7","author":"I Vernaleken","year":"2004","unstructured":"Vernaleken I, Siessmeier T, Buchholz HG, H\u00e4rtter S, Hiemke C, Stoeter P, R\u00f6sch F, Bartenstein P, Gr\u00fcnder G (2004) High striatal occupancy of D2-like dopamine receptors by amisulpride in the brain of patients with schizophrenia. Int J Neuropsychopharmacol 7:421\u2013430","journal-title":"Int J Neuropsychopharmacol"},{"key":"3091_CR61","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1016\/j.neuroimage.2010.10.041","volume":"54","author":"R Viviani","year":"2011","unstructured":"Viviani R (2011) Effects of large-scale nonstationarity on parametric maps. A study of rest perfusion CASL data. NeuroImage 54:2066\u20132078","journal-title":"NeuroImage"},{"key":"3091_CR62","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.neuroimage.2012.03.014","volume":"61","author":"R Viviani","year":"2012","unstructured":"Viviani R, Abler B, Seeringer A, Stingl JC (2012) Effect of paroxetine and bupropion on human resting brain perfusion: An arterial spin labelling study. NeuroImage 61:773\u2013779","journal-title":"NeuroImage"},{"key":"3091_CR63","first-page":"A168","volume":"42","author":"R Viviani","year":"2009","unstructured":"Viviani R, Beschoner P, Kirchheiner J, Abler B (2009a) Baseline brain perfusion in schizophrenia revisited: An arterial spin labelling study. Pharmacopsychiatry 42:A168","journal-title":"Pharmacopsychiatry"},{"key":"3091_CR64","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1471-2202-11-30","volume":"11","author":"R Viviani","year":"2010","unstructured":"Viviani R, Beschoner P, Lo H, Richter S, Haffer S, Osterfeld N, Th\u00f6ne J, Sim EJ (2010) Components of acquisition-to-acquisition variance in continuous arterial spin labelling (CASL) imaging. BMC Neurosci 11:30","journal-title":"BMC Neurosci"},{"key":"3091_CR65","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.neuroimage.2009.01.041","volume":"46","author":"R Viviani","year":"2009","unstructured":"Viviani R, Sim EJ, Lo H, Richter S, Haffer S, Osterfeld N, Th\u00f6ne J, Beschoner P (2009b) Components of variance in brain perfusion and the design of studies of individual differences: The baseline study. NeuroImage 46:12\u201322","journal-title":"NeuroImage"},{"key":"3091_CR66","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0925-4927(98)00033-X","volume":"83","author":"FX Vollenweider","year":"1998","unstructured":"Vollenweider FX, Maguire RP, Leenders KL, Mathys K, Angst J (1998) Effects of high amphetamine dose on mood and cerebral glucose metabolism in normal volunteers using positron emission tomography (PET). Psych Res Neuroimaging 83:149\u2013162","journal-title":"Psych Res Neuroimaging"},{"key":"3091_CR67","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1124\/jpet.110.172577","volume":"337","author":"DJJ Wang","year":"2011","unstructured":"Wang DJJ, Chen Y, Fern\u00e1ndez-Sara MA, Detre JA (2011) Potential and challenges for arterial spin labelling in pharmacological magnetic resonance imaging. J Pharmacol Exp Ther 337:359\u2013366","journal-title":"J Pharmacol Exp Ther"},{"key":"3091_CR68","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1148\/radiol.2351031663","volume":"235","author":"JJ Wang","year":"2005","unstructured":"Wang JJ, Zhang Y, Wolf RL, Roc AC, Alsop DC, Detre JA (2005) Amplitude-modulated continuous arterial spin-labeling 3.0-T perfusion MR imaging with a single coil: Feasibility study. Radiology 235:218\u2013228","journal-title":"Radiology"},{"key":"3091_CR69","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0014-2999(00)00935-3","volume":"412","author":"BHC Westerink","year":"2001","unstructured":"Westerink BHC, Kawahara Y, De Boer P, Geels C, De Vries JB, Wikstr\u00f6m HV, Van Kalkeren A, Van Vliet B, Kruse CG, Long SK (2001) Antipsychotic drugs classified by their effects on the release of dopamine and noradrenaline in the prefrontal cortex and striatum. Eur J Pharmacol 412:127\u2013138","journal-title":"Eur J Pharmacol"},{"key":"3091_CR70","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/BF00439443","volume":"97","author":"G Wik","year":"1989","unstructured":"Wik G, Wiesel FA, Sj\u00f6gren I, Blomquist G, Greitz T, Stone-Elander S (1989) Effects of sulpiride and chlorpromazine on regional cerebral glucose metabolism in schizophrenic patients as determined by positron emission tomography. Psychopharmacol (Berl) 97:309\u2013318","journal-title":"Psychopharmacol (Berl)"},{"key":"3091_CR71","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1073\/pnas.89.1.212","volume":"89","author":"DS Williams","year":"1992","unstructured":"Williams DS, Detre JA, Leigh JS, Koretsky AP (1992) Magnetic resonance imaging of perfusion using spin-inversion of arterial water. Proc Natl Acad Sci USA 89:212\u2013216","journal-title":"Proc Natl Acad Sci USA"},{"key":"3091_CR72","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/BF00177923","volume":"92","author":"A Wolkin","year":"1987","unstructured":"Wolkin A, Angrist B, Wolf A, Brodie J, Wolkin B, Jaeger J, Cancro R, Rotrosen J (1987) Effects of amphetamine on local cerebral metabolism in normal and schizophrenic subjects as determined by positron emission tomography. Psychopharmacol (Berl) 92:241\u2013426","journal-title":"Psychopharmacol (Berl)"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-013-3091-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00213-013-3091-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-013-3091-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T04:22:09Z","timestamp":1745986929000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00213-013-3091-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4,13]]},"references-count":72,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,9]]}},"alternative-id":["3091"],"URL":"https:\/\/doi.org\/10.1007\/s00213-013-3091-z","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,4,13]]}}}